Plasma concentration of Donepezil to the therapeutic response of Alzheimer's disease in Taiwanese

Journal of Alzheimer's Disease

Volumn 23, Issue 3, 2011, Pages 391-397

  Yang, Yuan Han ^a,c   Wu, Shey Lin ^d,e,f   Chou, Mei Chuan ^c   Lai, Chiou Lian ^a,c   Chen, Su Hwei ^b   Liu, Ching Kuan ^a,g  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^e DA YEH UNIVERSITY   (Taiwan)

^f NATIONAL YUNLIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^g KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Alzheimer's disease; Clinical Dementia Rating Scale sum of boxes; donepezil; Mini Mental Status Examination; Taiwanese

Indexed keywords

APOLIPOPROTEIN E; DONEPEZIL;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING SCALE SUM OF BOXES; COGNITION; DEMOGRAPHY; DRUG BLOOD LEVEL; FEMALE; FUNCTIONAL STATUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RATING SCALE; RECOMMENDED DRUG DOSE; TAIWAN; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 79951922271     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-100936     Document Type: Article

References (32)

1. Cummings JL (2004) Alzheimer's disease. N Engl J Med 351, 56-67.
2. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL (2001) Practice parameter: management of dementia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56, 1154-1166. (Pubitemid 32405709)
3. SmallGW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, Gwyther LP, Khachaturian ZS, Lebowitz BD, McRae TD, Morris JC, Oakley F, Schneider LS, Streim JE, Sunderland T, Teri LA, Tune LE (1997) Diagnosis and treatment of Alzheimer's disease and related disorders: consensus statement of the American Association of Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 278, 1363-1371. (Pubitemid 27449698)
4. Rogers SL, Friedhoff LT (1996) The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US multicentre, randomized, doubleblind, placebo-controlled trial. The Donepezil Study Group. Dementia 7, 293-303. (Pubitemid 26341258)
5. Soares JC, Gershon S (1995) THA - historical aspects, review of pharmacological properties and therapeutic effects. Dementia 6, 225-234.
6. Winblad B, Engedal K, Soininen H, Verhey F, Waldemar G, Wimo A, Wetterholm AL, Zhang R, Haglund A, Subbiah P, Donepezil Nordic Study Group (2001) A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57, 489-495. (Pubitemid 32757598)
7. Choi SH, Kim SY,Na HR, Kim BK,YangDW,Kwon JC, Park MY(2008) Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 25, 445-450. (Pubitemid 351630078)
8. MacGowan, SH, Wilcock GK, Scott M (1998) Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease. Int J Geriatr Psychiatry 13, 625-630. (Pubitemid 28441962)
9. Cacabelos R, Llovo R, Fraile C, Fernández-Novoa L (2007) Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of CYP2D6 in Alzheimer's disease pharmacogenetics. Curr Alzheimer Res 4, 479-500. (Pubitemid 47416643)
10. Pilotto A, Franceschi M, D'Onofrio G, Bizzarro A, Mangialasche F, Cascavilla L, Paris F, Matera MG, Pilotto A, Daniele A, Mecocci P, Masullo C, Dallapiccola B, Seripa D (2009) Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease. Neurology 73, 761-767.
11. Haywood WM, Mukaetova-Ladinska EB (2006) Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease. Am J Geriatr Pharmacother 4, 273-286. (Pubitemid 44575966)
12. Csernansky JG, Wang L, Miller JP, Galvin JE, Morris JC (2005) Neuroanatomical predictors of response to donepezil therapy in patients with dementia. Arch Neurol 62, 1718-1722. (Pubitemid 41626669)
13. Burns A, Rossor M, Hecker J, Gauthier S, Petit H, Möller HJ, Rogers SL, Friedhoff LT (1999) The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord 10, 237-244. (Pubitemid 29224502)
14. Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG (2004) Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a metaanalysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry 19, 624-633. (Pubitemid 38996839)
15. Darreh-Shori T, Meurling L, Pettersson T, Hugosson K, Hellström-Lindahl E, Andreasen N, Minthon L, Nordberg A (2006) Changes in the activity and protein levels of CSF acetylcholinesterases in relation to cognitive function of patients with mild Alzheimer's disease following chronic donepezil treatment. J Neural Transm 113, 1791-1801. (Pubitemid 44657676)
16. Soreq H, Seidman S (2001) Acetylcholinesterase-new roles for an old actor. Nat Rev Neurosci 2, 294-302.
17. McKhann G, Drachman DA, Folstein M, Katzman R, Price DL, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease-report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
18. Folstein MF, Folstein SE, McHugh PE (1975) A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
19. Lin KN,Wang PN, LiuCY, ChenWT, Lee YC, LiuHC(2002) Cut-off scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord 14, 176-182.
20. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44, 2308-2314. (Pubitemid 24382728)
21. Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412-2414. (Pubitemid 23346995)
22. Yeh HH, Yang YH, Ko JY, Chen SH (2008) Sensitive analysis of donepezil in plasma by capillary electrophoresis combining oncolumn field-amplified sample stacking and its application in Alzheimer's disease. Electrophoresis 29, 3649-3657.
23. Rogers SL, Doody RS, Mohs RC, Friedhoff LT (1998) Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebocontrolled study. Donepezil Study Group. Arch Intern Med 158, 1021-1031. (Pubitemid 28213580)
24. Cacabelos R (2005) Pharmacogenomics and therapeutic prospects in Alzheimer's disease. Exp Opin Pharmacother 6, 1967-1987. (Pubitemid 41613329)
25. Sramek JJ, Cutler NR (2000) RBC Cholinesterase Inhibition: A Useful Surrogate Marker for Cholinesterase Inhibitor Activity in Alzheimer Disease Therapy? Alz Dis Assoc Disord 14, 216-227.
26. Rogers SL, Friedhoff LT, for the Donepezil study group (1996) The efficacy and safety in patients with Alzheimer's disease: results of a US multicentre, randomized, doubleblind, placebo-controlled trail. Dementia 7, 293-303. (Pubitemid 26341258)
27. Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S, Donepezil "402" Study Group (2004) Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 61, 1852-1856. (Pubitemid 39612945)
28. Doody RS, Ferris SH, Salloway S, Sun Y, Goldman R, Watkins WE, Xu Y, Murthy AK (2009) Donepezil treatment of patients with MCI: a 48-week randomized, placebocontrolled trial. Neurology 72, 1555-1561.
29. Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopes OL, Cummings J, Xu Y, Feldman HH (2009) Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dement Geriatr Cogn Disord 28, 244-251.
30. Chen HH, Hu CJ (2006) Genetic characteristics of dementia in Taiwan. Acta Neurol Taiwan 15, 161-169.
31. Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL (1998) Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci 160, 67-75.
32. Burns A, Yeates A, Akintade L, Del Valle M, Zhang RY, Schwam EM, Perdomo CA (2008) Defining treatment response to donepezil in Alzheimer's disease: responder analysis of patient-level data from randomized, placebocontrolled studies. Drugs Aging 25, 707-714.